share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Apr 23 16:31

Gainers

  • 180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million.
  • ABVC BioPharma (NASDAQ:ABVC) shares rose 5.22% to $1.42. The company's market cap stands at $15.0 million.
  • Medpace Hldgs (NASDAQ:MEDP) stock increased by 5.15% to $427.5. The company's market cap stands at $13.2 billion. The company's, Q1 earnings came out yesterday.
  • Adverum Biotechnologies (NASDAQ:ADVM) stock increased by 5.0% to $11.55. The market value of their outstanding shares is at $239.7 million.
  • Black Diamond Therapeutic (NASDAQ:BDTX) stock moved upwards by 4.99% to $5.26. The market value of their outstanding shares is at $272.0 million.
  • Verve Therapeutics (NASDAQ:VERV) shares rose 4.94% to $7.22. The company's market cap stands at $603.7 million.

Losers

  • Fresh2 Group (NASDAQ:FRES) shares fell 12.9% to $0.39 during Tuesday's after-market session. The company's market cap stands at $9.6 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) stock fell 12.66% to $0.51. The market value of their outstanding shares is at $13.3 million.
  • Alterity Therapeutics (NASDAQ:ATHE) stock decreased by 11.22% to $1.9. The company's market cap stands at $16.5 million.
  • Tiziana Life Sciences (NASDAQ:TLSA) shares decreased by 10.65% to $0.69. The company's market cap stands at $69.4 million.
  • Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 7.91% to $0.15. The market value of their outstanding shares is at $7.5 million.
  • Nuwellis (NASDAQ:NUWE) shares fell 7.06% to $0.28. The company's market cap stands at $1.9 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment